Controlling Cardiac Arrhythmias: New Drugs in Development and Insights From Molecular Biology

Abstract

Get full access to this article

View all access options for this article.

References

Pearson TA , Smith SC , Poole-Wilson P. Cardiovascular specialty societies and the emerging global burden of cardiovascular disease: A call to action. Circulation 97:602, 1998

Packer M. Effects of beta-adrenergic blockade on survival of patients with chronic heart failure. Am J Cardiol 80:46L, 1997

Pitt B. , Segal R. , Martinez FA , et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) . Lancet 349(9054):747,1997

The Cardiac Arrhythmia Suppression Trial Investigators. Increased mortality due to encainide or flecainide in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321:406,1989

The Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 327:227,1992

Waldo AL , Camm AJ , deRuyter H. , et al., for the SWORD Investigators. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 348:7, 1996

Danish Investigations of Arrhythmia and Mortality on Dofetilide. Dofetilide in patients with left ventricular dysfunction and either heart failure or acute myocardial infarction: rationale, design, and patient characteristics of the DIAMOND studies. Clinical Cardiology 20:704,1997

Amiodarone Trials Meta-Analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: Meta-analysis of individual data from 6500 patients in randomised trials. Lancet 350:1417, 1997

Cairns JA , Connolly SJ , Roberts R. , Gent M. , for the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 349:675, 1997

10.

Julian DG , Camm AJ , Frangin G. , Janse MJ , Munoz A. , Schwartz PJ , Simon P. , for the European Myocardial Infarct Amiodarone Trial Investigators. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 349:667,1997

11.

Roden DM , Lazzara R. , Rosen M. , Schwartz PJ , Towbin J. , Vincent GM Multiple mechanisms in the long QT syndrome. Circulation 94:1996, 1996

12.

Brugada R. , Tapscott T. , Czernuszewicz GZ , et al. Identification of a genetic locus for familial atrial fibrillation . N Engl J Med 336:905,1997

13.

Sanguinetti MC , Jiang C. , Curran ME , Keating MT A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 81:299,1995

14.

Pinto JM , Boyden PA Reduced inward rectifying and increased E-4031-sensitive K+ current density in arrhythmogenic subendocardial Purkinje myocytes from the infarcted heart . J Cardiovasc Electrophysiol 9:299, 1998

15.

Nabauer M. , Kaab S. Potassium channel down-regulation in heart failure. Cardiovasc Res 37:324,1997

16.

Van Wagoner DR , Pond AL , McCarthy PM , Trimmer JS , Nerbonne JM K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ Res 80:772, 1997

17.

Yong SL , McLarnon JG , Walker Mja. RSD 1025: A mixed Ito and INa blocker with antiarrhythmic properties in the rat (abstract). FASEB J 12:A101,1998

18.

Barrett TD , Hayes ES , Yong SL , Walker ML , Beatch GN , Walker Mja. Ischemia selective electrophysiological and antiarrhythmic actions of RSD1019 in ischemic cardiac tissue (abstract). J Molec Cell Cardiol 29:A204,1998

19.

Karam R. , Marcello S. , Brooks RR , Corey AE , Moore A. Azimilide hydrochloride, a novel antiarrhythmic agent. Am J Cardiol 81:40D, 1998

20.

Camm AJ , Karam R. , Pratt CM The Azimilide Post-Infarct Survival Evaluation (ALIVE) Trial. Am J Cardiol 81: 35D, 1998

21.

Manning A. , Thisse V. , Hodeige D. , Richard J. , Heyndrickx JP , Chatelain P. SR 33589, a new amiodarone-like antiarrhythmic agent: Electrophysiological effects in anesthetized dogs. J Cardiovasc Pharmacol 25:252, 1995

22.

Hodeige D. , Heyndrickx JP , Chatelain P. , Manning A. SR 33589, a new amiodarone-like antiarrhythmic agent: Anti-adrenoceptor activity in anesthetized dogs. Eur J Pharmacol 279:25, 1995

23.

Scholz W. , Albus U. , Counillon L. , et al. Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischemia and reperfusion. Cardiovasc Res 29:260,1995

24.

Mahaffey KW , Puma JA , Barbagelata A. , et al. Does adenosine in conjunction with thrombolysis reduce infarct size? Results from the controlled, randomized AMISTAD trial. Circulation 96:1206, 1997

25.

Castle NA , Hollinshead SP , Hughes PF , et al. WO-09804521-A1 05-FEB-98

26.

Saffitz JE Gap junctions: Functional effects of molecular structure and tissue distribution . Adv Exp Med Biol 430:291,1997

27.

Hansen DE , Stacy GPJr , Taylor LK , Jobe RL , Wang Z. , Denton PK , Alexander J.Jr. Calcium- and sodium-dependent modulation of stretch-induced arrhythmias in isolated canine ventricles. Am J Physiol 268:H1803, 1995

28.

Salata JJ , Jurkiewicz NK , Wang J. , Evans BE , Orme HT , Sanguinetti MC A novel benzodiazepine that activates cardiac slow delayed rectifier K+ currents . Mol Pharmacol 54:220, 1998